← back to search

Zhiwan Dong

Wilmington University · US
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, and Neuroblastoma Research and Treatments.
h-index
14
citations
1,607
works
48
NIH funding
primary concept
email

Recent publications

Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
Journal for ImmunoTherapy of Cancer 2015cited by 234position: middledoi
Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
Cancer Immunology Research 2014cited by 140position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jianda Yuan · Merck & Co., Inc., Rahway, NJ, USA (United States)2 papers (2014–2015)Phillip Wong · Hudson Institute of Medical Research2 papers (2014–2015)Jedd D. Wolchok · Cornell University2 papers (2014–2015) · 1 papers (2015–2015)F. Stephen Hodi · Harvard University1 papers (2014–2014) · 1 papers (2015–2015)Xinqi Wu · Dana-Farber Cancer Institute1 papers (2014–2014)Manuarii Manuel · Université Claude Bernard Lyon 11 papers (2015–2015)Katherine S. Panageas · Bayer (Germany)1 papers (2014–2014)Sapna Tandon · Cornell University1 papers (2014–2014)Michael A. Postow · Memorial Sloan Kettering Cancer Center1 papers (2015–2015) · 1 papers (2015–2015)David B. Page · Providence Portland Medical Center1 papers (2014–2014) · 1 papers (2015–2015)Jarushka Naidoo · Johns Hopkins Bayview Medical Center1 papers (2014–2014)Deborah Kuk · Inspire Institute1 papers (2014–2014) · 1 papers (2015–2015)Jun Zhou · Xiamen University1 papers (2014–2014)Cailian Liu · Xiamen University1 papers (2015–2015)